Journal of Molecular and Cellular Cardiology
Volume 42, Issue 2 , Pages 304-314 , February 2007

Stem cell therapy enhances electrical viability in myocardial infarction

  • William R. Mills

      Affiliations

    • The Heart and Vascular Research Center, MetroHealth Campus, Case Western Reserve University, Cleveland, OH 44109, USA
    • ,
  • Niladri Mal

      Affiliations

    • Department of Cell Biology, Cleveland, OH 44109, USA
    • ,
  • Matthew J. Kiedrowski

      Affiliations

    • Department of Cell Biology, Cleveland, OH 44109, USA
    • ,
  • Ryan Unger

      Affiliations

    • Department of Cell Biology, Cleveland, OH 44109, USA
    • ,
  • Farhad Forudi

      Affiliations

    • Department of Cell Biology, Cleveland, OH 44109, USA
    • ,
  • Zoran B. Popovic

      Affiliations

    • Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH 44109, USA
    • ,
  • Marc S. Penn

      Affiliations

    • Department of Cell Biology, Cleveland, OH 44109, USA
    • Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH 44109, USA
    • The Center for Stem Cell and Regenerative Medicine, Cleveland, OH 44109, USA
    • ,
  • Kenneth R. Laurita

      Affiliations

    • The Heart and Vascular Research Center, MetroHealth Campus, Case Western Reserve University, Cleveland, OH 44109, USA
    • The Center for Stem Cell and Regenerative Medicine, Cleveland, OH 44109, USA
    • Corresponding Author InformationCorresponding author. Rammelmamp 6th Floor, Case Western Reserve University, MetroHealth Campus, 2500 MetroHealth Drive, Cleveland, OH 44109, USA. Tel.: +1 216 778 7342; fax: +1 216 778 1261.

Received 1 May 2006 ,Revised 12 September 2006 ,Accepted 20 September 2006.

References 

  1. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med. 1998;4:929–933
  2. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701–705
  3. Yau TM, Tomita S, Weisel RD, Jia ZQ, Tumiati LC, Mickle DAG, et al. Beneficial effect of autologous cell transplantation on infarcted heart function: comparison between bone marrow stromal cells and heart cells. Ann. Thorac. Surg. 2003;75:169–176
  4. Menasche P, Hagege AA, Scorsin M, Pouzet B, Desnos M, Duboc D, et al. Myoblast transplantation for heart failure. Lancet. 2001;357:279–280
  5. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 2002;106:3009–3017
  6. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002;106:1913–1918
  7. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet. 2003;361:45–46
  8. Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet. 2003;361:47–49
  9. Makkar RR, Lill M, Chen PS. Stem cell therapy for myocardial repair: is it arrhythmogenic?. J. Am. Coll. Cardiol. 2003;42:2070–2072
  10. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 2003;41:1078–1083
  11. Smits PC, van Geuns RJ, Poldermans D, Bountioukos M, Onderwater EE, Lee CH, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J. Am. Coll. Cardiol. 2003;42:2063–2069
  12. Fernandes S, Amirault JC, Lande G, Nguyen JM, Forest V, Bignolais O, et al. Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias. Cardiovasc. Res. 2006;69:348–358
  13. Reinecke H, MacDonald GH, Hauschka SD, Murry CE. Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J. Cell. Biol. 2000;149:731–740
  14. Fouts KH, Fernandes B, Mal N, Liu JQ, Laurita KR. Electrophysiological consequence of skeletal myoblast transplantation in normal and infarcted canine myocardium. Heart Rhythm. 2006;3:452–461
  15. Thompson RB, Emani SM, Davis BH, van den Bos EJ, Morimoto Y, Craig D, et al Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells. Circulation. 2003;108(Suppl. 1):II264–II271
  16. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004;364:141–148
  17. Valiunas V, Doronin S, Valiuniene L, Potapova I, Zuckerman J, Walcott B, et al. Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. J. Physiol. 2004;555:617–626
  18. Potapova I, Plotnikov A, Lu Z, Danilo P, Valiunas V, Qu J, et al. Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circ. Res. 2004;94:952–959
  19. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet. 2003;362:697–703
  20. Jain M, DerSimonian H, Brenner DA, Ngoy S, Teller P, Edge AS, et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation. 2001;103:1920–1927
  21. Deglurkar I, Mal N, Mills W, Popovic ZB, Kiedrowski MJ, Forudi F, McCarthy PM, Blackstone EH, Laurita KR, Penn MS. Mechanical and electrical effects of cell therapy are independent. Hum Gene Ther in press.
  22. Askari A, Unzek S, Goldman CK, Ellis SG, Thomas JD, DiCorleto PE, et al. Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy. J. Am. Coll. Cardiol. 2004;43:1908–1914
  23. Morgan EE, Faulx MD, McElfresh TA, Kung TA, Zawaneh MS, Stanley WC, et al. Validation of echocardiographic methods for assessing left ventricular dysfunction in rats with myocardial infarction. Am. J. Physiol. Heart. Circ. Physiol. 2004;287:H2049–H2053
  24. Mills WR, Mal N, Forudi F, Popovic ZB, Penn MS, Laurita KR. Optical mapping of late myocardial infarction in rats. Am. J. Physiol. Heart Circ. Physiol. 2006;290:H1298–H1306
  25. Laurita KR, Chuck ET, Yang T, Dong WQ, Kuryshev YA, Brittenham GM, et al. Optical mapping reveals conduction slowing and impulse block in iron-overload cardiomyopathy. J. Lab. Clin. Med. 2003;142:83–89
  26. Chang M, Emokpae R, Zhang Y, Tung L, Marban E, Abraham RA. Co-culture of mesenchymal stem cells and neonatal rat ventricular myocytes produces an arrhythmic substrate. Heart Rhythm. 2005;S48:[Abstract]
  27. Laurita KR, Girouard SD, Rosenbaum DS. Modulation of ventricular repolarization by a premature stimulus. Role of epicardial dispersion of repolarization kinetics demonstrated by optical mapping of the intact guinea pig heart. Circ. Res. 1996;79:493–503
  28. Eloff BC, Lerner DL, Yamada KA, Schuessler RB, Saffitz JE, Rosenbaum DS. High resolution optical mapping reveals conduction slowing in connexin43 deficient mice. Cardiovasc. Res. 2001;51:681–690
  29. Abraham MR, Henrikson CA, Tung L, Chang MG, Aon M, Xue T, et al. Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ. Res. 2005;97:159–167
  30. Krucoff MW, Crater S, Taylor DA, Soliman AM, Morimoto Y. Cell location may be a primary determinant of safety after myoblast transplantation into the infarcted heart. JACC. 2004;43:15
  31. Downey JM, Measuring infarct size by the tetrazolium method. Available at: http://www.usouthal.edu/ishr/help/ttc. 2005.
  32. Girouard SD, Laurita KR, Rosenbaum DS. Unique properties of cardiac action potentials recorded with voltage-sensitive dyes. J. Cardiovasc. Electrophysiol. 1996;7:1024–1038
  33. Gaudesius G, Miragoli M, Thomas SP, Rohr S. Coupling of cardiac electrical activity over extended distances by fibroblasts of cardiac origin. Circ. Res. 2003;93:421–428
  34. Delorme B, Dahl E, Jarry-Guichard T, Briand J-P, Willecke K, Gros D, et al. Expression pattern of connexin gene products at the early developmental stages of the mouse cardiovascular system. Circ. Res. 1997;81:423–437
  35. Van Kempen MJA, Vermeulen JLM, Moorman AFM, Gros D, Paul DL, Lamers WH. Developmental changes of connexin40 and connexin43 mRNA distribution patterns in the rat heart. Cardiovasc. Res. 1996;32:886–900
  36. Alcoléa S, Théveniau-Ruissy M, Jarry-Guichard T, Marics I, Tzouanacou E, Chauvin JP, et al. Downregulation of connexin 45 gene products during mouse heart development. Circ. Res. 1999;84:1365–1379
  37. Tang YL, Zhao Q, Qin X, Shen L, Cheng L, Ge J, et al. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann. Thorac. Surg. 2005;80:229–236

PII: S0022-2828(06)00919-9

doi: 10.1016/j.yjmcc.2006.09.011

Journal of Molecular and Cellular Cardiology
Volume 42, Issue 2 , Pages 304-314 , February 2007

Article Tools

* Image Usage & Resolution